Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 260-265 , May 2008

Understanding differences between high and low volume hospitals for radical prostatectomy

Received 6 February 2007 ,Revised 28 March 2007 ,Accepted 3 April 2007.

References 

  1. Hollenbeck BK, Dunn RL, Miller DC, et al. Volume-based referral for cancer surgery: informing the debate. J Clin Oncol. 2007;25:91–96
  2. Yao SL, Lu-Yao G. Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay. J Natl Cancer Inst. 1999;91:1950–1956
  3. Hu JC, Gold KF, Pashos CL, et al. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 2003;21:401–405
  4. Ellison LM, Trock BJ, Poe NR, et al. The effect of hospital volume on cancer control after radical prostatectomy. J Urol. 2005;173:2094–2098
  5. Chang SS, Cole E, Smith JA, et al. Safely reducing length of stay after open radical retropubic prostatectomy under the guidance of a clinical care pathway. Cancer. 2005;104:747–751
  6. Healthcare cost and utilization project. http://www.ahrq.gov/data/hcup/hcupnis.htmAccessed October 10, 2006
  7. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27
  8. American Hospital Association Annual Survey. http://www.aha.org/aha/index.jspAccessed June 6, 2006
  9. Panageas KS, Schrag D, Riedel E, et al. The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med. 2003;139:658–665
  10. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128–1137
  11. Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747–1751
  12. Ellison LM, Heaney JA, Birkmeyer JD. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol. 2000;163:867–869
  13. The Leapfrog Group. Purchasing Principles. Washington, DC: The Leapfrog Group; 2005;
  14. Bianco FJ, Eastham JA, Vickers AJ, et al. Impact of the radical prostatectomy surgical technique and surgeon experience on freedom from cancer recurrence. J Clin Oncol. 2006;24:4569;[Abstract].
  15. Bianco FJ, Riedel ER, Begg CB, et al. Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters. J Urol. 2005;173:2099–2103
  16. Galvin RS, Delbanco S, Milstein A, et al. Has the Leapfrog Group had an impact on the health care market?. Health Aff. 2005;24:228–233
  17. Dimick JB, Finlayson SR, Birkmeyer JD. Regional availability of high-volume hospitals for major surgery. Health Aff (Suppl Web Exclusive). 2004;45–53VAR
  18. Birkmeyer JD, Siewers AE, Marth NJ, et al. Regionalization of high-risk surgery and implications for patient travel times. JAMA. 2003;290:2703–2708
  19. Finlayson SR, Birkmeyer JD, Tosteson AN, et al. Patient preferences for location of care: implications for regionalization. Med Care. 1999;37:204–209
  20. Birkmeyer NJ, Wei Y, Goldfaden A, et al. Characteristics of hospitals performing bariatric surgery. JAMA. 2006;295:282–284
  21. Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: the problem with small sample size. JAMA. 2004;292:847–851
  22. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346:1138–1144
  23. Koch MO, Smith JA, Hodge EM, et al. Prospective development of a cost-efficient program for radical retropubic prostatectomy. Urology. 1994;44:311–318
  24. Koch MO, Smith JA. Influence of patient age and comorbidity on outcome of a collaborative care pathway after radical prostatectomy and cystoprostatectomy. J Urol. 1996;155:1681–1684
  25. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117–2127

☆ B.K.H. is supported in part by a grant from the John and Suzanne Munn Endowed Research Fund of the University of Michigan Comprehensive Cancer Center.

PII: S1078-1439(07)00099-3

doi: 10.1016/j.urolonc.2007.04.001

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 260-265 , May 2008

Article Tools